These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 23945108)

  • 21. Expression profile of microrna-145 in urothelial bladder cancer.
    Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR
    Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
    Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
    Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment.
    Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A
    Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
    Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
    Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A MicroRNA expression profile defining the invasive bladder tumor phenotype.
    Wszolek MF; Rieger-Christ KM; Kenney PA; Gould JJ; Silva Neto B; Lavoie AK; Logvinenko T; Libertino JA; Summerhayes IC
    Urol Oncol; 2011; 29(6):794-801.e1. PubMed ID: 19945312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of microRNAs associated with Gleason grading system in prostate cancer: miR-182-5p is a useful marker for high grade prostate cancer.
    Tsuchiyama K; Ito H; Taga M; Naganuma S; Oshinoya Y; Nagano K; Yokoyama O; Itoh H
    Prostate; 2013 Jun; 73(8):827-34. PubMed ID: 23184537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
    Busacca S; Germano S; De Cecco L; Rinaldi M; Comoglio F; Favero F; Murer B; Mutti L; Pierotti M; Gaudino G
    Am J Respir Cell Mol Biol; 2010 Mar; 42(3):312-9. PubMed ID: 19502386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel microRNA targets based on microRNA signatures in bladder cancer.
    Ichimi T; Enokida H; Okuno Y; Kunimoto R; Chiyomaru T; Kawamoto K; Kawahara K; Toki K; Kawakami K; Nishiyama K; Tsujimoto G; Nakagawa M; Seki N
    Int J Cancer; 2009 Jul; 125(2):345-52. PubMed ID: 19378336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential miRNA expression profiles in bladder urothelial carcinomas.
    Song T; Xia W; Shao N; Zhang X; Wang C; Wu Y; Dong J; Cai W; Li H
    Asian Pac J Cancer Prev; 2010; 11(4):905-11. PubMed ID: 21133599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
    Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
    Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
    Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
    Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression ratio of miR-17-5p and miR-155 correlates with grading in canine splenic lymphoma.
    Albonico F; Mortarino M; Avallone G; Gioia G; Comazzi S; Roccabianca P
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):117-23. PubMed ID: 23871213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
    Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
    Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection.
    Patnaik SK; Kannisto E; Knudsen S; Yendamuri S
    Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.